These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 23803333)
1. Novel oral prostacyclin analog with thromboxane synthase inhibitory activity for management of pulmonary arterial hypertension. Tran QK; Watanabe H Circ J; 2013; 77(8):1994-5. PubMed ID: 23803333 [No Abstract] [Full Text] [Related]
2. Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. Nakamura A; Nagaya N; Obata H; Sakai K; Sakai Y; Yoshikawa M; Hamada K; Matsumoto K; Kimura H Circ J; 2013; 77(8):2127-33. PubMed ID: 23676973 [TBL] [Abstract][Full Text] [Related]
3. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. Kataoka M; Nagaya N; Satoh T; Itoh T; Murakami S; Iwase T; Miyahara Y; Kyotani S; Sakai Y; Kangawa K; Ogawa S Am J Respir Crit Care Med; 2005 Dec; 172(12):1575-80. PubMed ID: 16192456 [TBL] [Abstract][Full Text] [Related]
4. Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats. Obata H; Sakai Y; Ohnishi S; Takeshita S; Mori H; Kodama M; Kangawa K; Aizawa Y; Nagaya N Am J Respir Crit Care Med; 2008 Jan; 177(2):195-201. PubMed ID: 17975203 [TBL] [Abstract][Full Text] [Related]
11. A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury. Hirata Y; Shimabukuro M; Uematsu E; Soeki T; Yamada H; Sakai Y; Nakayama M; Matsumoto K; Igarashi T; Sata M Eur J Pharmacol; 2012 Jan; 674(2-3):352-8. PubMed ID: 22094066 [TBL] [Abstract][Full Text] [Related]
12. Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Langleben D; Christman BW; Barst RJ; Dias VC; Galiè N; Higenbottam TW; Kneussl M; Korducki L; Naeije R; Riedel A; Simonneau G; Hirsch AM; Rich S; Robbins IM; Oudiz R; McGoon MD; Badesch DB; Levy RD; Mehta S; Seeger W; Solèr M Am Heart J; 2002 May; 143(5):E4. PubMed ID: 12040360 [TBL] [Abstract][Full Text] [Related]
13. Selective and nonselective inhibition of thromboxane formation. FitzGerald GA; Oates JA Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554 [TBL] [Abstract][Full Text] [Related]
14. [Chronic arterial occlusive diseases--drug therapy and thromboxane A2 synthetase inhibitor]. Yasuda K; Matsui Y; Goda T; Sakuma M; Go K Nihon Rinsho; 1991 Sep; 49(9):2149-54. PubMed ID: 1960880 [No Abstract] [Full Text] [Related]
15. Alternatives to nitric oxide. Lowson SM Br Med Bull; 2004; 70():119-31. PubMed ID: 15531733 [TBL] [Abstract][Full Text] [Related]
16. Effects of CGS-13080, a thromboxane inhibitor, on pulmonary vascular resistance in patients after mitral valve replacement surgery. Kim YD; Foegh ML; Wallace RB; Ng L; Ahmed SW; Katz NM; Siegelman R; Franco K; Douglas F; Ku E Circulation; 1988 Sep; 78(3 Pt 2):I44-50. PubMed ID: 3409518 [TBL] [Abstract][Full Text] [Related]
17. Single injection of ONO-1301-loaded PLGA microspheres directly after ischaemia reduces ischaemic damage in rats subjected to middle cerebral artery occlusion. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T J Pharm Pharmacol; 2012 Mar; 64(3):353-9. PubMed ID: 22309267 [TBL] [Abstract][Full Text] [Related]
18. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780 [TBL] [Abstract][Full Text] [Related]
19. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors. Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169 [TBL] [Abstract][Full Text] [Related]